Irinotecan–temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial

Rajen Mody, Arlene Naranjo, Collin Van Ryn, +11

The Lancet Oncology

Cog Anbl1221Neuro-oncologyGliomaMedicineNeurology +2

Impact of Extent of Resection on Local Control and Survival in Patients From the COG A3973 Study With High-Risk Neuroblastoma

Daniel von Allmen, Andrew M. Davidoff, Wendy B. London, +7

Journal of Clinical Oncology

Surgical OncologyCancer ManagementInterdisciplinary NeurosurgeryMultimodalitySurgery +23

Association of <i>MYCN</i> copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group

Kevin Campbell, Julie M. Gastier‐Foster, Meegan Mann, +11

Cancer

MYCN amplification and ATRX mutations are incompatible in neuroblastoma

Maged Zeineldin, Sara M. Federico, Xiang Chen, +33

Nature Communications

Assessment of Primary Site Response in Children With High-Risk Neuroblastoma: An International Multicenter Study

Rochelle Bagatell, Kieran McHugh, Arlene Naranjo, +18

Journal of Clinical Oncology

MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children’s oncology group

Risa Niemas-Teshiba, Ryosuke Matsuno, Larry Wang, +18

Oncotarget

MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group

Steven G. DuBois, Rajen Mody, Arlene Naranjo, +14

Pediatric Blood & Cancer

Antitumor Activity and Tolerability of hu14.18-IL2 with GMCSF and Isotretinoin in Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Phase II Study

Suzanne Shusterman, Arlene Naranjo, Collin Van Ryn, +11

Clinical Cancer Research

Prevalence and Clinical Correlations of Somatostatin Receptor-2 (SSTR2) Expression in Neuroblastoma

Natasha Alexander, Paula Marrano, Paul S. Thorner, +7

Journal of Pediatric Hematology/Oncology

PathologySomatostatin Receptor-2High-grade GliomasGliomaTumor Biology +14

Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma

Susana Galli, Arlene Naranjo, Collin Van Ryn, +11

American Journal Of Pathology

Neuro-oncologyPathologyNeuropeptide ReceptorNeuroprotectionNeurology +5